This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Using your skills to make money is a smart move. Explore various strategies to effectively leverage your talents and boost your earnings.
20,136 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Michael Burry’s shorts going strong have produced noticeable gains in select AI-adjacent bets, prompting a timely deb...
An insider move at a biotech stage company can spark questions. This article breaks down the trade, its timing, and w...
Block is pushing a bold crypto-backed play inside its fintech ecosystem. This article breaks down what the move could...
As 2026 unfolds, the crypto market presents both opportunity and risk. This guide outlines the best cryptocurrencies ...
Could Litecoin actually be a smarter buy than Bitcoin right now? This guide breaks down the differences, risks, and p...
The U.S. government has expanded direct stakes in select public firms, tying national security goals to market moves ...
VOOG surged in a blistering rally before facing headwinds as rates climbed and big tech leadership shifted. Here's wh...
First Trust AIRR, a small-cap industrial-focused ETF, has surged in 2026 and boasts a five-year performance well ahea...
A Capitol Hill probe into Epstein-era ties turned volatile this week, with lawmakers veering from policy questions to...
Ethereum hovers near a pivotal price band that previously sparked a major move. On-chain activity is rising as trader...
Noom is shifting from psychology-based weight loss to prescription treatments, launching Noom Med in a multi-state ro...